levonorgestrel has been researched along with dydrogesterone in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 3 (37.50) | 2.80 |
Authors | Studies |
---|---|
Campagnoli, C; Druckmann, R; Huber, J; Pasqualini, JR; Schindler, AE; Schweppe, KW; Thijssen, JH | 1 |
Varma, TR | 1 |
Tokhunts, KA | 1 |
El Behery, MM; Ibrahiem, MA; Kamal, EM; Kassem, GA; Mohamed, Mel S; Saleh, HS | 1 |
Asl, YA; Seidi, S; Yamini, Y | 1 |
Chen, HX; Fang, GZ; Hou, LP; Huang, GY; Ma, DD; Shi, WJ; Xie, L; Ying, GG; Zhang, JG | 1 |
Hu, D; Qian, M; Sun, Y | 1 |
Li, SY; Liu, F; Long, XB; Lu, ZJ; Ma, DD; Shi, WJ; Ying, GG; Zhang, JG | 1 |
1 review(s) available for levonorgestrel and dydrogesterone
Article | Year |
---|---|
Classification and pharmacology of progestins.
Topics: Female; Humans; Molecular Structure; Progestins; Receptors, Progesterone; Structure-Activity Relationship | 2003 |
1 trial(s) available for levonorgestrel and dydrogesterone
Article | Year |
---|---|
Levonorgestrel-releasing intrauterine device versus dydrogesterone for management of endometrial hyperplasia without atypia.
Topics: Administration, Oral; Adult; Dydrogesterone; Egypt; Endometrial Hyperplasia; Endometrium; Female; Humans; Hysterectomy; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Patient Satisfaction; Recurrence; Remission Induction; Time Factors; Treatment Outcome; Ultrasonography | 2015 |
6 other study(ies) available for levonorgestrel and dydrogesterone
Article | Year |
---|---|
Effect of long-term therapy with estrogen and progesterone on the endometrium of post-menopausal women.
Topics: Aged; Atrophy; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dydrogesterone; Endometrium; Estradiol; Estrogens; Estrogens, Conjugated (USP); Estrone; Female; Humans; Hyperplasia; Levonorgestrel; Menopause; Middle Aged; Norethindrone; Norgestrel; Progestins; Time Factors | 1985 |
[Pathogenetic correction of reproductive function disorder in patients with normogonadotropic ovary deficiency caused by body mass deficiency].
Topics: Adolescent; Adult; Amenorrhea; Body Mass Index; Drug Combinations; Dydrogesterone; Emaciation; Estradiol; Female; Gonadotropins; Humans; Infertility, Female; Levonorgestrel; Primary Ovarian Insufficiency | 2007 |
Development of a microfluidic-chip system for liquid-phase microextraction based on two immiscible organic solvents for the extraction and preconcentration of some hormonal drugs.
Topics: Adult; Alkanes; Dydrogesterone; Female; Humans; Lab-On-A-Chip Devices; Levonorgestrel; Liquid Phase Microextraction; Medroxyprogesterone; Methanol; Polymethyl Methacrylate; Solvents | 2016 |
Levonorgestrel and dydrogesterone affect sex determination via different pathways in zebrafish.
Topics: Animals; Dydrogesterone; Female; Levonorgestrel; Male; Sex Differentiation; Water Pollutants, Chemical; Zebrafish | 2021 |
Clinical efficacy of levonorgestrel intrauterine system (Mirena) combined with hysteroscopy in the treatment of perimenopausal AUB patients.
Topics: Case-Control Studies; Combined Modality Therapy; Dydrogesterone; Female; Humans; Hysteroscopy; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Perimenopause; Random Allocation; Time Factors; Treatment Outcome; Uterine Hemorrhage | 2021 |
Dydrogesterone and levonorgestrel at environmentally relevant concentrations have antagonist effects with rhythmic oscillation in brain and eyes of zebrafish.
Topics: Animals; Brain; Dydrogesterone; Levonorgestrel; Male; Period Circadian Proteins; Water Pollutants, Chemical; Zebrafish; Zebrafish Proteins | 2022 |